Pharmacological targeting of the IL-17/neutrophil axis attenuates calcific deposits in rat models of calciphylaxis

By afschroeder • October 2, 2025

Tao B, Cao EZ, Hyun J, Ramadoss S, Alvarez JF, Su L, Sun Q, Liu Z, Zhang L, Espinoza A, Gu Y, Ma F, Li S, Pellegrini M, Deb A. Pharmacological targeting of the IL-17/neutrophil axis attenuates calcific deposits in rat models of calciphylaxis. J Clin Invest. 2025 Aug 15;135(19):e190369. doi: 10.1172/JCI190369. PMID: 41031886; PMCID: PMC12483568.

Tags: Bone disease, Cardiology/Epi, cell biology, dermatology, Neutrophils, Post Doc, Publications, skin

Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change

White JP, Song J, Kim ST, Zappacosta H, Cho PD, McKay S, Girish A, Abramov A, Daniel M, Telesca D, Husain M, Ardehali A. Waitlist[...]

Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart transplant recipients in the United States

Zappacosta H, Daniel M, Tan N, Cho PD, Song J, White JP, Ardehali A. Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart[...]

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry

Hijazi W, Zhou J, Miller RJH, Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Kavanagh PB, Parekh T, Liang JX, Alexanderson E, Carvajal-Juarez I, Slipczuk[...]